Breaking News Instant updates and real-time market news.

AAPL

Apple

$217.65

-2.35 (-1.07%)

, CRM

Salesforce

$155.46

-0.07 (-0.05%)

09:14
09/24/18
09/24
09:14
09/24/18
09:14

Apple, Salesforce announce strategic partnership

Apple and Salesforce announced a strategic partnership that brings together the number one customer relationship management platform and iOS, the world's most advanced mobile operating system, enabling powerful new mobile apps for business. Working with Apple, Salesforce is redesigning its app to embrace the native mobile platform with exclusive new features on iOS. The companies will also provide tools and resources for millions of Salesforce developers to build their own native apps with a new Salesforce Mobile SDK for iOS, and a new iOS app development course on Trailhead, Salesforce's free, web-based learning platform. The redesigned Salesforce Mobile App will add exclusive new features on iOS, including Siri Shortcuts integrated with Salesforce Einstein Voice. "We're excited to work with Salesforce and that their industry-leading CRM will embrace native iOS and deliver exclusive new features on iPhone and iPad," said Tim Cook, Apple's CEO. "With the powerful combination of iPhone, iPad and iOS - the best hardware and software for business - together with native Salesforce apps and the new Salesforce SDK, we can deliver great customer experiences for businesses around the world." "With this partnership, we're bringing together the world's #1 CRM platform with iPhone and iPad, the world's best devices for business," said Marc Benioff, Chairman and co-CEO, Salesforce. "Together, Salesforce and Apple are defining a new era of mobile innovation with native apps on iOS, and empowering millions of people with access to Trailhead and the skills they need for the jobs of the future." The initial focus areas of this strategic partnership include: Native Salesforce iOS apps for business: Salesforce, working with Apple, will redesign the Salesforce Mobile App to give customers rich experiences exclusively on iOS, with unique Apple capabilities such as Siri Shortcuts, Face ID, Business Chat and more. Salesforce will also introduce the first ever Trailhead Mobile App, first on iOS. The partners will also deliver powerful iOS apps for industries and small business that will serve their specific customer needs. Empowering Salesforce developers on iOS: Apple and Salesforce are developing the first Salesforce Mobile SDK that is optimized for Swift(TM), Apple's powerful and intuitive modern programming language. The native SDK will enable businesses and developers to build and deploy apps for iPhone and iPad on the Salesforce Lightning Platform, adding to the hundreds of thousands of iOS apps for business in the App Store today. Accelerating developer learning and career growth: Apple and Salesforce believe strongly in the democratization of technology and empowering developers - with any education level or background - to learn skills for the jobs of today and tomorrow. To support developer learning and career growth, Apple is launching a new Get Started with iOS App Development Trail that will teach anyone how to build native iOS apps in Xcode with Swift.

AAPL

Apple

$217.65

-2.35 (-1.07%)

CRM

Salesforce

$155.46

-0.07 (-0.05%)

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 03

    Mar

AAPL Apple
$217.65

-2.35 (-1.07%)

09/24/18
RSBL
09/24/18
NO CHANGE
RSBL
Buy
Rosenblatt says Apple iPhone XS, Max first weekend sales stronger than iPhone X
Rosenblatt analyst Jun Zhang said his channel checks indicate that first weekend sales for the new iPhone XS and iPhone XS Max are higher than they were for the iPhone X, which he attributes mainly to a better production ramp for the iPhone XS and Max. However, he continues to believe total iPhone XS and Max sales will be lower than total iPhone X sales over a two-month period as his research suggests the iPhone XS order pipeline is "very weak." Zhang maintains a Buy rating on Apple shares.
09/24/18
RBCM
09/24/18
NO CHANGE
Target $240
RBCM
Outperform
Carrier discounts for iPhone 'more attractive' in this cycle, says RBC Capital
RBC Capital analyst Amit Daryanani kept his Outperform rating and $240 price target on Apple, saying the carrier promotions for its latest iPhone line-up are "relatively more attractive" and should produce a "healthy" volume result. The analyst cites the "$700-off on a new line at multiple carriers, along with better trade-in values" generating a smaller hurdle for potential buyers and believes that Apple can sustain "mid-single digit sales and low-to-mid teens EPS growth in a flattish iPhone volume growth environment".
09/21/18
CHLM
09/21/18
NO CHANGE
CHLM
Craig-Hallum calls STMicro, Skyworks 'winners' from early iPhone teardowns
Craig-Hallum analyst Anthony Stoss said he believes STMicroelectronics (STM) is the largest beneficiary of content expansion across all three iPhone models, noting that the company's eSIM is being found in early iPhone teardowns, as expected. Stoss points out that likely only 25% of the chips are being identified in the initial teardown on the iPhone XS/XS Max and reminds investors that typically only one-third of all the chips in Apple's (AAPL) phones are ever identified. With that said, he called Skyworks (SWKS) the "other big winner." Stoss added that his projection that likely over 60% of total phone volumes will come from the lower-cost iPhone XR is something he views as a positive for both Synaptics (SYNA) and Qorvo (QRVO).
09/21/18
NOMU
09/21/18
NO CHANGE
NOMU
Neutral
Qorvo content not yet showing up in iPhone teardowns, says Nomura Instinet
Publicly available teardowns released so far for Apple's (AAPL) iPhone XS and XS Max have not identified a Qorvo (QRVO) part in either of the flagship phones, according to Nomura Instinet analyst Krysten Sciacca, who called this "surprising." Sciacca, who said she would have expected to find an envelope tracker alongside the Intel (INTC) baseband, continues to believe Qorvo has won additional tuning/antenna content, "which has historically been difficult, if not nearly impossible, to identify from a board photo." She also thinks Qorvo likely has higher content in the lower-cost iPhone XR, which will be released next month. Sciacca has a Neutral rating on Qorvo shares.
CRM Salesforce
$155.46

-0.07 (-0.05%)

09/21/18
WBLR
09/21/18
NO CHANGE
WBLR
William Blair does not see Marketo deal hurting HubSpot, Salesforce
William Blair analyst Bhavan Suri says that within his coverage universe, Marketo, just bought by Adobe Systems (ADBE), competes with HubSpot's (HUBS) Marketing Hub and Salesforce's (CRM) Marketing Cloud offerings. The analyst, who acknowledges that the acquisition will "somewhat change the competitive dynamics in the industry," does not believe the acquisition will have a "significant adverse impact" on either Salesforce or HubSpot. HubSpot and Marketo target two different segments of the market, Suri tells investors in a research note. He points out that Marketo now targets larger enterprise customers at the higher end of the business-to-business market, while HubSpot's customer base is "more diverse and spans small and midmarket B2C and B2B companies." As such, Suri believes there is little competitive impact for HubSpot from the Adobe deal. Further, he's not overly concerned about Salesforce, as he believes the company already has a strong ecosystem across its Marketing Cloud.
09/21/18
KEYB
09/21/18
NO CHANGE
Target $286
KEYB
Overweight
Adobe's acquisition for Marketo could be 'quite synergistic,' says KeyBanc
After Adobe (ADBE) announced plans to acquire Marketo for $4.8B, KeyBanc analyst Brent Bracelin says a deal could be "quite synergistic," and and views it as a critical growth engine for Adobe that, when combined with Magento, helps round out the Experience Cloud portfolio. Bracelin expects the deal could could expand Adobe's marketing segment run-rate to nearly $3B next year while increasing the competitive overlap with the marketing and commerce segments of Salesforce (CRM) and Oracle (ORCL). Bracelin has an Overweight rating and $286 price target on Adobe shares.
08/31/18
ARGS
08/31/18
NO CHANGE
Target $180
ARGS
Buy
Salesforce price target raised to $180 from $141 at Argus
Argus analyst Joseph Bonner raised his price target on Salesforce to $180 and kept his Buy rating after its "strong" Q2 results and raised FY guidance for the third time. The analyst notes that while investors were disappointing by next quarter's outlook and bid the shares down, he believes that the company is "well positioned" to exploit secular trends of "software as a service cloud solutions, data analytics, and platform software services". Bonner also raises his FY19 EPS view to $2.53 from $2.31, citing Salesforce's continued market share gains and cloud CRM space innovation.
08/31/18
BMOC
08/31/18
NO CHANGE
Target $165
BMOC
Outperform
Salesforce billings hurt by seasonality, pipeline still solid, says BMO Capital
BMO Capital analyst Keith Bachman kept his Outperform rating and $165 price target on Salesforce after its Q2 results, saying the integration of its recent MuleSoft acquisition has helped to "boost" revenues with its $122M contribution, deferred revenues and margins. The analyst notes that the company's billings were slightly "disappointing", but sees its pipeline remaining solid and the issues as transitory beyond seasonality. Bachman recommends that investors continue to accumulate shares, taking advantage of any "near-term weakness".

TODAY'S FREE FLY STORIES

SOR

Source Capital

$37.94

0.26 (0.69%)

17:02
11/12/18
11/12
17:02
11/12/18
17:02
Hot Stocks
Source Capital declares $3.20 per share special dividend »

Source Capital declared a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YRD

Yirendai

$15.47

-1.75 (-10.16%)

17:01
11/12/18
11/12
17:01
11/12/18
17:01
Earnings
Yirendai reports Q3 adjusted income per ADS 87c, consensus 52c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

LTM

Latam Airlines

$8.96

-0.39 (-4.17%)

17:00
11/12/18
11/12
17:00
11/12/18
17:00
Hot Stocks
Latam Airlines reports October passenger traffic up 1.5% »

LATAM Airlines Group …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

ETON

Eton Pharmaceuticals

$0.00

(0.00%)

16:53
11/12/18
11/12
16:53
11/12/18
16:53
Syndicate
Eton Pharmaceuticals 3.6M share IPO priced at $6.00 »

National Securities acted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENR

Energizer

$60.18

-1.235 (-2.01%)

16:49
11/12/18
11/12
16:49
11/12/18
16:49
Hot Stocks
Energizer names Patrick Moore chairman of the board »

Energizer Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ACIU

AC Immune

$8.74

0.01 (0.11%)

16:47
11/12/18
11/12
16:47
11/12/18
16:47
Initiation
AC Immune initiated  »

AC Immune initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRNT

Kornit Digital

$19.15

-0.88 (-4.39%)

16:47
11/12/18
11/12
16:47
11/12/18
16:47
Earnings
Kornit Digital reports Q3 adjusted EPS 13c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ZGNX

Zogenix

$40.82

0.05 (0.12%)

16:46
11/12/18
11/12
16:46
11/12/18
16:46
Initiation
Zogenix initiated  »

Zogenix initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ADMS

Adamas Pharmaceuticals

$11.45

-0.455 (-3.82%)

16:45
11/12/18
11/12
16:45
11/12/18
16:45
Initiation
Adamas Pharmaceuticals initiated  »

Adamas Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 27

    Nov

  • 27

    Nov

AGN

Allergan

$163.82

-1.77 (-1.07%)

16:45
11/12/18
11/12
16:45
11/12/18
16:45
Initiation
Allergan initiated  »

Allergan initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

SAGE

Sage Therapeutics

$121.50

-9.46 (-7.22%)

16:45
11/12/18
11/12
16:45
11/12/18
16:45
Initiation
Sage Therapeutics initiated  »

Sage Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 27

    Nov

  • 19

    Dec

NBIX

Neurocrine

$103.03

-2.18 (-2.07%)

16:44
11/12/18
11/12
16:44
11/12/18
16:44
Initiation
Neurocrine initiated  »

Neurocrine initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

HLUYY

Lundbeck

$0.00

(0.00%)

16:44
11/12/18
11/12
16:44
11/12/18
16:44
Initiation
Lundbeck initiated  »

Lundbeck initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWPH

GW Pharmaceuticals

$134.48

-3.3 (-2.40%)

16:43
11/12/18
11/12
16:43
11/12/18
16:43
Initiation
GW Pharmaceuticals initiated  »

GW Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

BHVN

Biohaven Pharmaceutical

$36.42

-2.47 (-6.35%)

16:42
11/12/18
11/12
16:42
11/12/18
16:42
Initiation
Biohaven Pharmaceutical initiated  »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 14

    Nov

  • 27

    Nov

ACAD

Acadia

$18.86

-0.01 (-0.05%)

16:42
11/12/18
11/12
16:42
11/12/18
16:42
Initiation
Acadia initiated  »

Acadia initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ALKS

Alkermes

$34.70

-2.98 (-7.91%)

16:41
11/12/18
11/12
16:41
11/12/18
16:41
Initiation
Alkermes initiated  »

Alkermes initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 14

    Nov

  • 31

    Jan

GATX

GATX

$76.43

-2.54 (-3.22%)

16:37
11/12/18
11/12
16:37
11/12/18
16:37
Hot Stocks
GATX acquires up to 3,100 railcars for $229M »

GATX Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVGS

Navigator Holdings

$12.03

-0.13 (-1.07%)

16:35
11/12/18
11/12
16:35
11/12/18
16:35
Earnings
Navigator Holdings reports Q3 EPS 1c, consensus (2c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

GRA

W.R. Grace

$63.83

-0.705 (-1.09%)

16:35
11/12/18
11/12
16:35
11/12/18
16:35
Hot Stocks
W.R. Grace to increase price for silica-based, molecular sieve products by 7% »

W. R. Grace will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQH

AXA Equitable

$21.09

-0.355 (-1.66%)

16:34
11/12/18
11/12
16:34
11/12/18
16:34
Hot Stocks
AXA Equitable reports Q3 annualized premiums up 2% »

Reports Q3 operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

EQH

AXA Equitable

$21.09

-0.355 (-1.66%)

16:33
11/12/18
11/12
16:33
11/12/18
16:33
Hot Stocks
Breaking Hot Stocks news story on AXA Equitable »

AXA Equitable announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

EQH

AXA Equitable

$21.09

-0.355 (-1.66%)

16:32
11/12/18
11/12
16:32
11/12/18
16:32
Earnings
AXA Equitable reports Q3 adjusted EPS $1.23, consensus 91c »

Reports Q3 revenue $1.08B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

HAL

Halliburton

$34.17

-0.81 (-2.32%)

16:31
11/12/18
11/12
16:31
11/12/18
16:31
Hot Stocks
Halliburton names Lance Loeffler as CFO, Chris Weber to leave company »

Halliburton is pleased to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELVT

Elevate Credit

$4.11

-0.08 (-1.91%)

16:31
11/12/18
11/12
16:31
11/12/18
16:31
Hot Stocks
Elevate Credit appoints David Peterson Chief Credit Officer »

Elevate Credit announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.